Lipid-containing lubricants for dry eye: A systematic review

Optometry and Vision Science

Volumn 89, Issue 11, 2012, Pages 1654-1661

  Lee, Sze Yee ^a   Tong, Louis ^a,b,c,d  

^a SINGAPORE EYE RESEARCH INSTITUTE   (Singapore)

^b SINGAPORE NATIONAL EYE CENTRE   (Singapore)

^c DUKE NUS MEDICAL SCHOOL   (Singapore)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

dry eye; eyedrops; human; lipid layer; liposomal spray

Indexed keywords

DRY EYE; EYE-DROPS; HUMAN; LIPID LAYERS; LIPOSOMAL SPRAY;

OPTOMETERS;

OPHTHALMOLOGY;

EYE DROPS; LIPID; LIPOSOME; LUBRICATING AGENT;

DRY EYE; HUMAN; REVIEW;

DRY EYE SYNDROMES; HUMANS; LIPIDS; LIPOSOMES; LUBRICANTS; OPHTHALMIC SOLUTIONS;

EID: 84869878071     PISSN: 10405488     EISSN: None     Source Type: Journal    
DOI: 10.1097/OPX.0b013e31826f32e0     Document Type: Review

References (33)

1. Lin PY, Tsai SY, Cheng CY, Liu JH, Chou P, Hsu WM. Prevalence of dry eye among an elderly Chinese population in Taiwan: the Shihpai Eye Study. Ophthalmology 2003;110:1096-101. (Pubitemid 36676639)
2. Mertzanis P, Abetz L, Rajagopalan K, Espindle D, Chalmers R, Snyder C, Caffery B, Edrington T, Simpson T, Nelson JD, Begley C. The relative burden of dry eye in patients' lives: comparisons to a U.S. normative sample. Invest Ophthalmol Vis Sci 2005; 46:46-50. (Pubitemid 40041177)
3. Reddy P, Grad O, Rajagopalan K. The economic burden of dry eye: a conceptual framework and preliminary assessment. Cornea 2004; 23:751-61. (Pubitemid 39447303)
4. Definition and Classification Subcommittee of the International Dry Eye WorkShop. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf 2007; 5:75-92.
5. Tiffany JM. The normal tear film. Dev Ophthalmol 2008;41:1-20.
6. Dilly PN. Structure and function of the tear film. Adv Exp Med Biol 1994;350:239-47. (Pubitemid 24130636)
7. Craig JP, Tomlinson A. Importance of the lipid layer in human tear film stability and evaporation. Optom Vis Sci 1997;74:8-13. (Pubitemid 27114503)
8. Knop E, Knop N, Millar T, Obata H, Sullivan DA. The international workshop on meibomian gland dysfunction: report of the subcommittee on anatomy, physiology, and pathophysiology of the meibomian gland. Invest Ophthalmol Vis Sci 2011;52: 1938-78.
9. Rieger G. Lipid-containing eye drops: a step closer to natural tears. Ophthalmologica 1990;201:206-12.
10. Trees GR, Tomlinson A. Effect of artificial tear solutions and saline on tear film evaporation. Optom Vis Sci 1990;67:886-90.
11. Sullivan LJ, McCurrach F, Lee S, Taylor HR, Rolando M, Marechal-Courtois C, Creuzot-Garcher C, Easty DL, Karabatsas C, Bingh Hoh M, Faschinger C, Laroche L. Efficacy and safety of 0.3% carbomer gel compared to placebo in patients with moderate-to-severe dry eye syndrome. Ophthalmology 1997;104: 1402-8. (Pubitemid 28116805)
12. Holly FJ. Artificial tear formulations. Int Ophthalmol Clin 1980;20:171-84.
13. Lasic DD, Papahadjopoulos D. Medical Applications of Liposomes. New York, NY: Elsevier; 1998.
14. Tetzlaff JM, Sterne JAC, Altman DG, Weeks L, Turner L. Assessing risk of bias in included studies. In: Higgins JPt, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions. Hoboken, NJ: Wiley-Blackwell; 2008:187-242.
15. Schünemann HJ, Oxman AD, Vist GE, Higgins JPT, Deeks JJ, Glasziou P, Guyatt GH. Interpreting results and drawing conclusions. In: Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions. Hoboken, NJ: Wiley-Blackwell; 2008:359-88.
16. Khaireddin R, Schmidt KG. [Comparative investigation of treatments for evaporative dry eye]. Klin Monbl Augenheilkd 2010;227:128-34.
17. Lee S, Dausch S, Maierhofer G, Dausch D. [A new therapy concept for the treatment of dry eyeYthe usefulness of phospholipid liposomes]. Klin Monbl Augenheilkd 2004;221:825-36. (Pubitemid 39490663)
18. Craig JP, Purslow C, Murphy PJ,Wolffsohn JS. Effect of a liposomal spray on the pre-ocular tear film. Cont Lens Anterior Eye 2010; 33:83-7.
19. Di Pascuale MA, Goto E, Tseng SC. Sequential changes of lipid tear film after the instillation of a single drop of a new emulsion eye drop in dry eye patients. Ophthalmology 2004;111:783-91. (Pubitemid 38429677)
20. Goto E, Shimazaki J, Monden Y, Takano Y, Yagi Y, Shimmura S, Tsubota K. Low-concentration homogenized castor oil eye drops for noninflamed obstructive meibomian gland dysfunction. Ophthalmology 2002;109:2030-5. (Pubitemid 35222556)
21. Khanal S, Tomlinson A, Pearce EI, Simmons PA. Effect of an oilin- water emulsion on the tear physiology of patients with mild to moderate dry eye. Cornea 2007;26:175-81. (Pubitemid 46168287)
22. Wang TJ, Wang IJ, Ho JD, Chou HC, Lin SY, Huang MC. Comparison of the clinical effects of carbomer-based lipidcontaining gel and hydroxypropyl-guar gel artificial tear formulations in patients with dry eye syndrome: a 4-week, prospective, open-label, randomized, parallel-group, noninferiority study. Clin Ther 2010; 32:44-52.
23. Stern ME, Gao J, Siemasko KF, Beuerman RW, Pflugfelder SC. The role of the lacrimal functional unit in the pathophysiology of dry eye. Exp Eye Res 2004;78:409-16. (Pubitemid 38183319)
24. Begley CG, Barr JT, Edrington TB, Long WD, McKenney CD, Chalmers RL. Characteristics of corneal staining in hydrogel contact lens wearers. Optom Vis Sci 1996;73:193-200. (Pubitemid 26112454)
25. Olson MC, Korb DR, Greiner JV. Increase in tear film lipid layer thickness following treatment with warm compresses in patients with meibomian gland dysfunction. Eye Contact Lens 2003; 29:96-9. (Pubitemid 43189076)
26. Rashid S, Jin Y, Ecoiffier T, Barabino S, Schaumberg DA, Dana MR. Topical omega-3 and omega-6 fatty acids for treatment of dry eye. Arch Ophthalmol 2008;126:219-25. (Pubitemid 351240851)
27. Rosenberg ES, Asbell PA. Essential fatty acids in the treatment of dry eye. Ocul Surf 2010;8:18-28.
28. Yoo SE, Lee DC, Chang MH. The effect of low-dose doxycycline therapy in chronic meibomian gland dysfunction. Korean J Ophthalmol 2005;19:258-63.
29. Foulks GN, Borchman D, Yappert M, Kim SH, McKay JW. Topical azithromycin therapy for meibomian gland dysfunction: clinical response and lipid alterations. Cornea 2010;29:781-8.
30. Sall K, Stevenson OD, Mundorf TK, Reis BL. Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group. Ophthalmology 2000;107:631-9. (Pubitemid 30191329)
31. Stevenson D, Tauber J, Reis BL. Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial. The Cyclosporin A Phase 2 Study Group. Ophthalmology 2000;107:967-74.
32. Pflugfelder SC. Antiinflammatory therapy for dry eye. Am J Ophthalmol 2004;137:337-42. (Pubitemid 38221009)
33. Avunduk AM, Avunduk MC, Varnell ED, Kaufman HE. The comparison of efficacies of topical corticosteroids and nonsteroidal anti-inflammatory drops on dry eye patients: a clinical and immunocytochemical study. Am J Ophthalmol 2003;136: 593-602. (Pubitemid 37153173)